Zephyr AI, a company building novel transparent AI to address unmet needs across the spectrum of precision medicine, and KangarooHealth, a healthcare tech company providing an AI-assisted remote patient monitoring platform and care management services, announced a strategic partnership to work toward providing clinicians with insights to inform treatment decisions for patients diagnosed with chronic conditions.

The partnership will combine Zephyr AI’s machine learning technology with KangarooHealth’s proprietary remote monitoring platform to work toward creating a predictive solution for clinicians. KangarooHealth is HIPAA and SOC2 certified,

“The opportunity to pair Zephyr’s machine learning platform with real-world data from a cutting-edge partner like KangarooHealth is tremendous,” says David L. Morgan II, CEO of Zephyr AI. “Together, we believe this collaboration will enable us to provide clinicians with the insights to be able to better anticipate and address the needs of their patients, deliver personalized treatment decisions, and ultimately improve individual health outcomes, and that service comes with the added benefit of reducing the total cost of care to the overall system.”

The company’s platform and connected device network will be integrated into Zephyr’s machine learning models, which leverage algorithms that forecast the development and progression of disease and adverse outcome events. Data from KangarooHealth’s comprehensive monitoring platform, which integrates with over 100 connected devices, including blood pressure monitors, blood glucose monitors, and other wearable technologies will accelerate Zephyr AI’s existing machine learning capabilities and enable clinicians to better predict and prevent adverse outcomes.

“We are creating a whole new dynamic in patient care,” added Xiaoxu Kang, PhD, KangarooHealth’s founder and CEO. “By combining accurate patient insights that have been generated using smart biometric devices with the ability to predict the trajectory of an illness, we aim to deliver physicians a list of options to identify warning signs and plan into early intervention opportunities for mitigating adverse events, thereby significantly helping prevent catastrophic outcomes.”